Atrial Septal Defect – Ostium Secundum type (Secundum ASD / Fossa Ovalis ASD)

An ostium secundum atrial septal defect is a birth-present hole in the thin wall (septum) between the two upper heart chambers (the atria). In the womb, every baby has a natural opening there to let blood flow while the lungs are not yet working. After birth, that opening is supposed to close. In a secundum ASD, the closing does not happen fully, so blood leaks from the left atrium (higher pressure) to the right atrium (lower pressure). Over time, too much blood goes to the right side of the heart and into the lungs. This can stretch the right atrium and right ventricle, cause heart rhythm problems, lower exercise capacity, and—after many years—raise the blood pressure in the lungs (pulmonary hypertension) if the hole is large. Doctors confirm the diagnosis with ultrasound of the heart (echocardiography) and decide on treatment (often catheter device closure, sometimes surgery) based on the size of the hole, the amount of extra flow (the shunt), right-heart enlargement, and lung blood-vessel resistance. Professional guidelines recommend closure when the shunt is significant (often expressed as Qp:Qs ≥ 1.5:1) and when the right side of the heart is enlarged from the extra flow. Oxford Academic+1

Atrial septal defect, ostium secundum (secundum ASD) is a hole in the wall between the heart’s two upper chambers (the atria), located in the central “fossa ovalis” area. Blood, which should go from the left side of the heart to the body, partly leaks across this hole from the left atrium to the right atrrium. That extra blood makes the right heart and lungs do more work. Many children feel fine for years. Adults can later develop problems like irregular heartbeats, shortness of breath, stroke from a clot crossing the hole, and high pressure in the lungs if the hole is large and untreated. The defect can be closed with a catheter device or surgery when it is significant and causes right-heart enlargement. Medicines do not close the hole; they only ease symptoms or treat complications. Merck Manuals+3NCBI+3PubMed Central+3

Blood normally moves from lungs → left heart → body. With a secundum ASD, oxygen-rich blood “short-circuits” back into the right heart and lungs. Over years, this can enlarge the right atrium and right ventricle and raise pressures in the lung arteries. Some people later develop atrial arrhythmias, heart failure symptoms, or paradoxical embolism (a clot crossing to the left side and causing stroke). If lung pressures rise a lot (rare with timely care), the shunt can reverse (right-to-left), which is dangerous and makes closure unsafe. PubMed Central+2PubMed Central+2

---

Other names

• Secundum ASD

• Ostium secundum ASD

• Fossa ovalis ASD

• Atrial septal defect, type II (ASD II)

• Sometimes people confuse this with a patent foramen ovale (PFO). A PFO is a flap-like channel, not a true hole with missing tissue; a secundum ASD is a true deficiency in the septal tissue. (Your care team uses echo to tell them apart.) ASE+1

---

Types

Even though “secundum ASD” is one category of ASD, there are variations inside this group. These details matter because they affect whether a catheter device can close the hole safely:

1. Single central (fossa ovalis) defect – the classic, round or oval hole in the middle of the atrial septum.

2. Fenestrated secundum ASD – multiple small openings clustered in the fossa ovalis region.

3. Large secundum ASD – a big gap that may stretch toward the edges (rims); device closure may be hard if rims are weak.

4. Aneurysmal septum with ASD – floppy, bulging septal tissue around a central opening; sometimes there are several tiny holes.

5. Rim-deficient secundum ASD – the edges near important structures (like the aorta, vena cavae, or tricuspid valve) are too small or absent, which can make device placement risky; surgery may be preferred.

6. Associated with PFO – a true ASD plus a PFO channel; closure strategy depends on anatomy. ASE+1

(Other ASD families—primum, sinus venosus, and coronary sinus defects—are different entities, with different anatomy and repair approaches. Secundum is by far the most common ASD in both children and adults.) Medscape

---

Causes

A secundum ASD is congenital, meaning it forms during early heart development in pregnancy. Many times, no single cause is found. But known risk factors and associations include:

1. Genetic variants in heart-development genes (for example GATA4, NKX2-5, TBX5, TBX20) that guide septum formation. These can run in families.

2. Chromosomal conditions, especially Down syndrome (Trisomy 21)—although primum AV canal is most typical, secundum ASD also occurs.

3. Holt–Oram syndrome (TBX5 mutations) with upper-limb changes and septal defects.

4. Noonan spectrum disorders, which can include several heart anomalies.

5. 22q11.2 deletion (DiGeorge spectrum) with conotruncal and septal anomalies.

6. Ellis–van Creveld syndrome and other ciliopathies that may involve atrial septal tissue.

7. Maternal diabetes in early pregnancy, which raises congenital heart defect risks.

8. Maternal rubella infection or other early fetal infections that disturb heart morphogenesis.

9. Maternal alcohol exposure (fetal alcohol spectrum) affecting septal development.

10. Maternal smoking and nicotine exposure, linked to higher congenital heart defect risk.

11. Retinoic acid (vitamin A derivative) exposure at high doses in early pregnancy.

12. Valproate and some antiepileptic drugs in the first trimester.

13. Maternal obesity before or early in pregnancy.

14. Assisted reproductive technologies (small increased CHD risk reported in studies).

15. Family history of congenital heart disease, especially a first-degree relative.

16. Intrauterine growth disturbances and placental problems during early organ formation.

17. Maternal autoimmune disease (e.g., anti-Ro/SSA) occasionally linked to fetal heart issues.

18. Nutritional deficiencies in very early pregnancy (e.g., folate), though evidence is mixed for isolated ASD.

19. Unknown multifactorial causes (most common—many cases have no identifiable single cause).

20. Syndromic clusters where ASD coexists with other organ anomalies because a shared developmental pathway was affected.

(These risk factors and gene associations are summarized across guideline reviews and reference texts on ASD; individual families should seek genetic counseling when there is a strong family history or other anomalies.) NCBI+1

---

Symptoms

Many children with small secundum ASDs feel fine. Larger ASDs often show up later (school age, teens, or even adulthood). Typical symptoms are due to extra blood flow through the right heart and lungs:

1. Shortness of breath with activity – the most common complaint in adolescents and adults.

2. Early tiredness or low exercise tolerance – getting winded sooner than peers.

3. Heart palpitations – awareness of a fast or irregular heartbeat.

4. Episodes of atrial arrhythmias – atrial flutter or atrial fibrillation can develop after years of right-atrial stretch.

5. Frequent respiratory infections in younger children due to high lung blood flow.

6. Chest discomfort (non-anginal) – a vague pressure or “awareness,” usually benign.

7. Swelling of ankles or feet – late sign if right-sided heart failure develops.

8. Lightheadedness or fainting (syncope) – less common; may be rhythm-related.

9. Poor weight gain or feeding difficulty in infants – when the shunt is large.

10. New exercise intolerance during pregnancy – pregnancy increases blood volume and can unmask a large shunt.

11. Headaches or migraine with aura – sometimes reported, especially if a PFO is also present.

12. Stroke or TIA at a young age – rare in isolated ASD but can happen from a clot passing across the defect (paradoxical embolus), especially if pressures transiently reverse.

13. Cyanosis with exertion – unusual unless pulmonary hypertension has developed; if present, it suggests advanced disease.

14. Heart murmur found on routine checkup – many are discovered this way.

15. Worsening breathlessness in mid-life – due to long-standing right-heart volume load or onset of pulmonary hypertension if untreated. PubMed Central+1

---

Diagnostic tests

A) Physical examination (what the clinician sees and hears)

1. General inspection – many people look normal at rest; advanced cases can show breathlessness with mild activity or ankle swelling.

2. Pulse and blood pressure – usually normal; in long-standing cases there may be signs of right-sided failure.

3. Neck veins (JVP) – may show a prominent “a” wave or volume loading in advanced cases.

4. Heart sounds – the classic clue is a fixed, wide split of the second heart sound (S2) that doesn’t vary much with breathing, due to delayed closure of the pulmonary valve from extra right-sided flow.

5. Murmur – typically an ejection flow murmur over the left upper sternal border from extra flow across the pulmonary valve; a soft mid-diastolic rumble at the lower left sternal border can reflect increased flow across the tricuspid valve.

6. Lung exam – usually clear; crackles suggest heart failure or another cause.

7. Liver and extremities – check for liver enlargement or leg swelling in late disease. PubMed Central

B) “Manual bedside maneuvers (simple, non-device tests the clinician may use)

8. Respiratory variation check – in a typical person the S2 split changes with breathing; in secundum ASD the split often stays widely “fixed”, which is a bedside clue.

9. Valsalva maneuver – briefly reduces venous return; in ASD, murmurs may soften but the fixed split character of S2 helps distinguish it from other causes.

10. Squat-to-stand (or passive leg raise) – increases venous return; flow murmurs may grow louder with increased right-sided flow. (These maneuvers support suspicion but do not confirm the diagnosis.) PubMed Central

C) Laboratory and pathological tests

11. Basic labs (CBC, CMP) – usually normal; in chronic right-heart failure there may be mild liver enzyme changes or fluid-related findings.

12. BNP or NT-proBNP – can be normal early; may rise if the right ventricle is strained.

13. Arterial oxygen saturation – normal at rest in most uncomplicated ASDs; low oxygen suggests right-to-left shunting (uncommon) or advanced pulmonary hypertension.

14. Genetic testing – considered when there is a strong family history or syndromic features (e.g., limb anomalies, facial features). This does not diagnose ASD by itself but can explain why it happened. NCBI

D) Electrodiagnostic tests

15. Electrocardiogram (ECG) – common patterns include incomplete right bundle branch block, right axis deviation, and signs of right atrial enlargement. Some adults show atrial flutter/fibrillation.

16. Ambulatory rhythm monitor (Holter or patch) – checks for intermittent atrial arrhythmias, especially when palpitations or stroke/TIA have occurred.

17. Exercise ECG testing – may uncover exercise-induced arrhythmias or reduced capacity; it helps with overall assessment, not with measuring the hole. PubMed Central

E) Imaging and hemodynamic tests (the cornerstone)

18. Transthoracic echocardiogram (TTE) with color Doppler – the primary test. It shows the hole, the direction of flow, and—importantly—right atrial and right ventricular enlargement from extra blood volume. Saline bubble study can show shunting. 3D echo adds detail. ASE

19. Transesophageal echocardiogram (TEE) – used when TTE images are not clear or to plan catheter device closure. TEE measures rims (the edges around the hole) and checks the relation to nearby structures to decide if a device is safe. It is also used during the procedure to guide device placement. ASE+1

20. Cardiac MRI (CMR) – very helpful when echo windows are limited or when precise shunt quantification (Qp:Qs) and right-ventricular volumes are needed. CT angiography can also define anatomy if MRI is not possible. Cardiac catheterization is reserved for measuring lung pressures and vascular resistance when pulmonary hypertension is suspected or when noninvasive tests disagree. Closure is generally recommended by major societies when Qp:Qs ≥ 1.5:1 with right-heart enlargement and acceptable pulmonary vascular resistance; it is not recommended when lung vascular disease is severe or when shunt is trivial. Oxford Academic+2American College of Cardiology+2

Non-pharmacological treatments (therapies & others)

1. Watchful follow-up with an adult congenital cardiologist
   Regular clinic visits and echocardiograms track heart size, pressures, and rhythm. Purpose: catch changes early and time closure. Mechanism: surveillance detects right-heart enlargement, arrhythmia, or rising pulmonary pressure so care can be adjusted. AHA Journals

2. Guideline-based timing of ASD closure
   Close if shunt is significant and anatomy is suitable. Purpose: prevent long-term complications (arrhythmias, heart failure, pulmonary hypertension, stroke). Mechanism: removing the shunt unloads the right heart and stops excess lung blood flow. PubMed Central

3. Transcatheter device closure education
   Explain benefits/risks of percutaneous closure using an occluder device. Purpose: informed consent and realistic expectations. Mechanism: double-disk device seals the hole; tissue grows over it. cardiovascular.abbott

4. Surgical closure planning
   Chosen if rims are deficient, defect is large/multiple, or other heart repairs are needed (e.g., anomalous pulmonary veins). Purpose: safe definitive repair. Mechanism: patch or primary suture restores the atrial wall. NCBI

5. Exercise prescription
   Most people with repaired or uncomplicated ASD can be active. Purpose: improve fitness, blood pressure, weight, mood. Mechanism: graded aerobic activity strengthens the cardiovascular system; plan individualized limits when needed. www.heart.org+1

6. Cardiac rehabilitation (when deconditioned or post-closure)
   Supervised exercise and education. Purpose: safe return to activity. Mechanism: monitored training improves exercise capacity and reduces symptoms. PubMed

7. Arrhythmia monitoring (Holter/event monitor)
   Detects silent atrial fibrillation/flutter. Purpose: prevent stroke and symptoms. Mechanism: early detection guides anticoagulation or ablation decisions. AHA Journals

8. Sleep apnea screening
   OSA worsens pulmonary pressures and atrial arrhythmia risk. Purpose: reduce strain on the right heart. Mechanism: treating OSA improves oxygenation and pulmonary hemodynamics. PubMed Central

9. Vaccinations (influenza, COVID-19, RSV for eligible infants)
   Prevent infections that can stress the heart/lungs. Purpose: reduce hospitalizations and lung complications. Mechanism: immune protection lowers inflammation and respiratory burden (e.g., nirsevimab for RSV in eligible infants). CDC+1

10. Dental hygiene and routine dental care
    Good oral care lowers bacteremia risk; IE prophylaxis is not routine except in high-risk settings (e.g., first 6 months after device/surgical repair or with residual prosthetic material). Purpose: reduce infective endocarditis risk. Mechanism: controlling oral bacteria reduces transient bacteremia. ADA+2PubMed Central+2

11. Healthy-weight and nutrition coaching (DASH/Mediterranean style)
    Emphasize fruits, vegetables, whole grains, lean protein, and low sodium. Purpose: support blood pressure, weight, and lipids. Mechanism: diet patterns improve vascular health and reduce cardiac workload. Verywell Health

12. Smoking cessation and avoidance of secondhand smoke
    Purpose: protect lung vessels and heart rhythm. Mechanism: stopping smoke exposure reduces pulmonary vascular damage and arrhythmia triggers. Verywell Health

13. Travel and DVT prevention counseling
    Hydration, periodic walking, and compression for long trips. Purpose: reduce clot risk that could cause paradoxical embolism. Mechanism: movement limits venous stasis; hydration keeps blood less viscous. Merck Manuals

14. Pregnancy planning with an ACHD team
    Pre-pregnancy assessment and timing of closure when indicated. Purpose: safer pregnancy. Mechanism: optimizing hemodynamics reduces maternal/fetal risk. AHA Journals

15. Return-to-sports guidance
    Most people with small/uncomplicated ASD can do regular sports; competitive decisions are individualized. Purpose: stay active safely. Mechanism: structured evaluation aligns sport intensity with cardiac status. JACC

16. Blood pressure, lipids, and glucose management
    Purpose: lower vascular strain and arrhythmia triggers. Mechanism: treating risk factors improves endothelial function and reduces afterload. Verywell Health

17. Alcohol moderation and stimulant avoidance
    Purpose: reduce atrial arrhythmias and dehydration. Mechanism: limiting triggers lowers AF risk and keeps blood volume stable. Merck Manuals

18. Education on warning signs
    Teach symptoms of stroke, AF, heart failure, and pulmonary hypertension. Purpose: prompt care saves brain and heart. Mechanism: early presentation enables effective treatment. Merck Manuals

19. Post-closure activity and lifting restrictions (temporary)
    Short-term limits after device/surgery per the treating team. Purpose: protect healing tissue or device position. Mechanism: limiting strain allows endothelialization of the device or patch. cardiovascular.abbott

20. Psychological support
    Anxiety is common in CHD; counseling helps. Purpose: improve quality of life and adherence. Mechanism: coping strategies reduce stress-related symptoms and improve self-care. ACHA

---

Drug treatments

Important note: No medicine can close a secundum ASD. Drugs support symptoms or treat complications (heart failure, arrhythmias, pulmonary hypertension, clot risk, or post-closure care). Always follow your cardiologist’s plan.

1. Furosemide (loop diuretic)
   Class/Dose/Time: Loop diuretic; typical adult 20–40 mg orally once–twice daily (adjusted).
   Purpose/Mechanism: Relieves fluid overload and breathlessness by increasing urine output; reduces right-heart volume load.
   Side effects: Low potassium, dehydration, kidney effects. Merck Manuals

2. Spironolactone (MRA)
   Dose: 12.5–25 mg daily (titrate).
   Purpose: Add-on diuretic; potassium-sparing.
   Mechanism: Blocks aldosterone, easing congestion.
   Side effects: High potassium, gynecomastia. Merck Manuals

3. Thiazide diuretics (e.g., hydrochlorothiazide)
   Dose: 12.5–25 mg daily.
   Purpose: Additional gentle diuresis for BP and edema control.
   Side effects: Low sodium/potassium, gout. Merck Manuals

4. ACE inhibitors (e.g., enalapril)
   Dose: 2.5–20 mg/day.
   Purpose: Treat heart failure symptoms or hypertension.
   Mechanism: Lowers afterload and neurohormonal activation.
   Side effects: Cough, kidney function changes, high potassium. Merck Manuals

5. ARBs (e.g., losartan)
   Dose: 25–100 mg/day.
   Purpose/Mechanism: Alternative to ACE-I; lowers afterload.
   Side effects: Dizziness, kidney effects, hyperkalemia. Merck Manuals

6. Beta-blockers (e.g., metoprolol)
   Dose: 25–200 mg/day (varies).
   Purpose: Control heart rate; reduce palpitations or AF.
   Mechanism: Slows conduction and reduces arrhythmia burden.
   Side effects: Fatigue, low heart rate, hypotension. AHA Journals

7. Non-dihydropyridine calcium-channel blockers (diltiazem/verapamil)
   Purpose: Rate control in AF/flutter when appropriate.
   Mechanism: Slow AV-node conduction.
   Side effects: Low blood pressure, constipation; avoid in some heart failure. AHA Journals

8. Class IC antiarrhythmics (e.g., flecainide)
   Purpose: Rhythm control in selected patients without structural ventricular disease.
   Mechanism: Sodium-channel blockade to maintain sinus rhythm.
   Side effects: Proarrhythmia; specialist use. AHA Journals

9. Amiodarone
   Purpose: Rhythm control when others fail.
   Mechanism: Multi-channel effects; maintains sinus rhythm.
   Side effects: Thyroid, lung, liver, eye effects; requires monitoring. AHA Journals

10. Anticoagulants (warfarin or DOACs)
    Purpose: Stroke prevention in AF or after thromboembolism.
    Mechanism: Reduces clot formation that could pass across or form in the atria.
    Side effects: Bleeding; dosing/INR or renal checks needed. AHA Journals

11. Antiplatelet therapy after device closure (e.g., aspirin ± short course clopidogrel)
    Purpose: Prevent device-related thrombus while tissue grows over the device.
    Mechanism: Inhibits platelet aggregation on device surfaces.
    Side effects: Bleeding/bruise risk; duration per operator protocol. cardiovascular.abbott

12. Pulmonary vasodilators (sildenafil)
    Purpose: For selected patients with pulmonary arterial hypertension (PAH) when closure is not possible.
    Mechanism: Enhances nitric-oxide pathway to lower pulmonary pressure.
    Side effects: Headache, flushing, hypotension. PubMed Central

13. Endothelin-receptor antagonists (bosentan/ambrisentan)
    Purpose/Mechanism: Lower pulmonary vascular resistance in CHD-PAH/Eisenmenger scenarios under specialist care.
    Side effects: Liver enzyme elevation, edema. PubMed Central

14. Prostacyclin-pathway agents (epoprostenol, treprostinil, selexipag)
    Purpose: Advanced PAH therapy if indicated.
    Mechanism: Potent pulmonary vasodilation and antiproliferative effects.
    Side effects: Flushing, jaw pain; infusion risks. PubMed Central

15. SGLT2 inhibitors (e.g., dapagliflozin) for HF with reduced EF
    Purpose: If LV systolic dysfunction coexists.
    Mechanism: Osmotic diuresis and cellular effects reduce HF events.
    Side effects: Genital infections; volume depletion. AHA Journals

16. Digoxin
    Purpose: Rate control or symptomatic relief in selected AF/HF.
    Mechanism: Increases vagal tone and inotropy.
    Side effects: Narrow therapeutic window; toxicity risk. AHA Journals

17. Loop diuretic IV (e.g., IV furosemide) for acute decompensation
    Purpose: Rapid relief of congestion.
    Mechanism: Potent natriuresis.
    Side effects: Electrolyte shifts, kidney effects. Merck Manuals

18. Iron therapy for proven deficiency
    Purpose: Treat iron-deficiency-related fatigue or HF intolerance when present.
    Mechanism: Restores oxygen-carrying capacity.
    Side effects: GI upset (oral) or infusion reactions (IV). AHA Journals

19. Antibiotics only when indicated (e.g., actual infection or special IE-prophylaxis windows)
    Purpose: Treat infection; prophylaxis limited to first 6 months after closure or with residual prosthetic material.
    Mechanism: Reduces bacteremia risk during dental work in those narrow indications.
    Side effects: Drug-specific. www.heart.org+1

20. Proton-pump inhibitor when antithrombotics cause dyspepsia/bleeding risk
    Purpose: GI protection.
    Mechanism: Lowers stomach acid.
    Side effects: Nutrient malabsorption with long-term use. (Clinical practice adjunct; not ASD-specific.) AHA Journals

---

Dietary molecular supplements

1. Omega-3 fatty acids (fish oil or diet)
   Dose: Foods preferred; supplements often 1–2 g/day EPA+DHA if advised.
   Function/Mechanism: Anti-inflammatory, triglyceride-lowering; may help general cardiovascular health. Not ASD-specific. Verywell Health

2. Soluble fiber (oats, barley, psyllium)
   Dose: 5–10 g/day soluble fiber.
   Function: Improves lipids and satiety; supports heart health. Verywell Health

3. Potassium-rich foods
   Dose: Dietary sources (bananas, beans, greens) unless restricted.
   Function: Helps blood pressure control; avoid if on potassium-sparing meds or with kidney issues. Verywell Health

4. Magnesium (diet ± supplement)
   Dose: Typically 200–400 mg/day if deficient.
   Function: Supports rhythm stability and BP; check renal function and drug interactions. Verywell Health

5. Coenzyme Q10
   Dose: 100–200 mg/day.
   Function: Mitochondrial cofactor; may ease statin-associated symptoms and support energy; evidence mixed. Verywell Health

6. Vitamin D (if deficient)
   Dose: Per lab guidance (often 800–2000 IU/day).
   Function: General health; deficiency is common and correcting it supports bones and immunity; not ASD-specific. Verywell Health

7. Beetroot (dietary nitrates)
   Dose: Food forms preferred.
   Function: Short-term BP reduction via nitric oxide; avoid in advanced PAH without specialist advice. Verywell Health

8. Folate/B12 (if homocysteine elevated or dietary deficiency)
   Dose: As indicated (e.g., folate 400–800 mcg/day).
   Function: Lowers homocysteine; mixed outcome data. Verywell Health

9. Plant sterols/stanols
   Dose: ~2 g/day.
   Function: Modestly lowers LDL cholesterol; part of diet therapy. Verywell Health

10. Green leafy vegetables and nuts (diet pattern emphasis)
    Dose: Daily servings.
    Function: Provide minerals, fiber, and healthy fats that support BP and lipids. Verywell Health

---

Immunity-booster / regenerative / stem-cell drugs

There are no approved regenerative or stem-cell drugs to heal or close a secundum ASD. The only “immunity-type” medicines relevant are vaccinations and, in special infant cases, preventive monoclonal antibodies against RSV during the first season. Below are appropriate, evidence-based preventive options used for general and respiratory health, not for closing the ASD:

1. Influenza vaccine (annual) — reduces flu complications that stress heart and lungs. Pediatrics

2. COVID-19 vaccination — protects against severe respiratory illness; follow current schedules. Pediatrics

3. RSV preventive antibody (nirsevimab) for infants in first RSV season — effective in preventing severe RSV; used per ACIP/AAP guidance. CDC+1

4. RSV prevention for older high-risk infants (per evolving guidance) — specialist will advise. CDC

5. Pneumococcal vaccines (per age/risk) — reduce pneumonia risk. Pediatrics

6. Routine childhood/adult immunizations per schedule — overall infection reduction supports cardiac health. Pediatrics

---

Surgeries / procedures

1. Transcatheter device closure
   Procedure: A catheter delivers a metal mesh occluder that opens like two umbrellas to seal the hole; the heart’s lining grows over it.
   Why: First-line when rims are adequate and there is right-heart volume overload from the shunt. Benefits: faster recovery, no sternotomy. PubMed Central+1

2. Surgical patch closure via median sternotomy
   Procedure: Heart-lung machine; surgeon closes ASD with a patch (pericardium or synthetic) or direct suture if small.
   Why: For very large defects, deficient rims, multiple fenestrations, or coexisting lesions needing repair. NCBI

3. Minimally invasive surgical closure (mini-thoracotomy/thoracoscopic)
   Procedure: Smaller incision access with patch or suture closure.
   Why: Cosmetic and recovery advantages when anatomy and team expertise allow. NCBI

4. Surgical repair when anomalous pulmonary venous return coexists
   Procedure: Redirects pulmonary veins to the left atrium plus ASD patch closure.
   Why: Fixes the associated lesion that precludes device closure. PubMed Central

5. Management of device-related complications (rare)
   Procedure: Retrieval/re-position or surgical removal if device embolizes, erodes, or thromboses.
   Why: Safety response when rare complications occur. cardiovascular.abbott

---

 Preventions

1. Timely evaluation and closure when indicated (prevents long-term complications). PubMed Central

2. Regular ACHD follow-up and rhythm checks (prevents silent AF-related stroke). AHA Journals

3. Vaccinations per schedule (reduce respiratory stressors). Pediatrics

4. Dental hygiene; IE prophylaxis only in the narrow, guideline-specified windows after repair. ADA+1

5. Heart-healthy eating (DASH/Mediterranean) and weight control. Verywell Health

6. Regular, safe physical activity. www.heart.org

7. No smoking; avoid secondhand smoke. Verywell Health

8. Manage blood pressure, lipids, and diabetes. Verywell Health

9. Plan pregnancy with an ACHD team. AHA Journals

10. Travel clot prevention (movement, hydration; discuss anticoagulation if AF). Merck Manuals

---

When to see a doctor

• New or worsening shortness of breath, swelling, or exercise intolerance.

• Palpitations, dizziness, fainting, or known atrial fibrillation/flutter.

• Any signs of stroke/TIA: face droop, arm weakness, speech trouble—call emergency services immediately.

• Blue lips or fingers, especially with exertion (possible shunt reversal).

• Fever with recent dental work after device/surgical repair (discuss IE risk).

• Pregnancy planning or early pregnancy.

• Before starting vigorous sports or a new high-intensity program. AHA Journals+1

---

What to eat and what to avoid

• Eat more: vegetables, fruits, beans, whole grains, nuts, seeds, olive oil, fish; choose low-salt options; drink water. These patterns support blood pressure, lipids, and weight. Verywell Health

• Limit: salty snacks, processed meats, refined sugars, trans-fats, heavy alcohol, and energy drinks/stimulants (arrhythmia triggers). Verywell Health

---

Frequently asked questions

1. Can medicine close a secundum ASD?
   No. Medicines treat symptoms or complications; closure is by device or surgery when indicated. PubMed Central

2. How do doctors decide to close it?
   They look for a significant left-to-right shunt with right-heart enlargement, symptoms, or complications, and suitable anatomy. PubMed Central

3. Is catheter (device) closure safe?
   Yes for suitable defects; recovery is quick, and serious complications are uncommon in experienced centers. PubMed Central

4. When is surgery preferred?
   Very large/multiple holes, poor rims, or other heart issues needing repair. NCBI

5. What if lung pressure is high?
   Advanced pulmonary hypertension (Eisenmenger) can make closure unsafe; specialists manage with PAH medicines and supportive care. PubMed Central

6. Do I need antibiotics before dental work forever?
   No. Only for the first 6 months after closure or if there is residual prosthetic material. Otherwise, routine prophylaxis is not recommended. www.heart.org+1

7. Can I exercise?
   Most people with repaired or uncomplicated ASD can exercise; get individualized advice from an ACHD team. www.heart.org

8. Will closing the ASD prevent stroke?
   It reduces paradoxical embolism risk and long-term complications but stroke risk also depends on rhythm (e.g., AF) and other factors. Merck Manuals

9. How long do I take aspirin after device closure?
   Your cardiologist will specify, commonly for months while the device endothelializes. cardiovascular.abbott

10. Is pregnancy safe?
    Often safe after appropriate evaluation and, if needed, closure beforehand. Always plan with an ACHD specialist. AHA Journals

11. Can a small ASD be left alone?
    Yes if small, with no right-heart enlargement or symptoms; it is monitored over time. AHA Journals

12. Will my child outgrow the ASD?
    Some small secundum ASDs may close early in life; significant defects usually require closure. Merck Manuals

13. Is device erosion a risk?
    It’s rare; careful sizing and anatomical selection minimize risk. Follow post-procedure instructions. cardiovascular.abbott

14. Do I need lifelong follow-up?
    Yes—periodic ACHD follow-up is recommended even after closure to monitor rhythm and valve or pulmonary pressures. AHA Journals

15. Does diet really matter for ASD?
    Diet won’t close the hole, but heart-healthy eating supports blood pressure, weight, and vascular health, which helps long-term outcomes. Verywell Health

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 26, 2025.

PDF Documents For This Disease Condition References